Not all opioid drug testing panels detect the same substances.
That’s where many workplace drug testing programs run into confusion.
A standard opiates panel is typically designed to detect naturally occurring opiates such as morphine and codeine. While important, that coverage may not automatically include other commonly discussed substances like oxycodone, fentanyl, or tramadol.
Expanded opioid panels are designed to provide broader visibility. Depending on the configuration, they may include:
-
Oxycodone
-
Hydrocodone
-
Fentanyl
-
Tramadol
-
Additional synthetic or semi-synthetic opioids
This distinction matters because different opioids behave differently in the body and may require separate targeted screening.
For employers, the goal is not simply “more testing.” It’s choosing panel configurations that align with workplace realities, industry risk, and program objectives. A healthcare organization, treatment center, or safety-sensitive employer may require different opioid coverage than a general office environment.
It’s also important to understand that fentanyl testing is often added separately and may not be included in every standard panel by default.
As opioid trends continue to evolve, reviewing panel configurations carefully becomes increasingly important.
Fact Friday takeaway:
Not all opioid panels are the same. Understanding what your test actually screens for helps ensure your program aligns with workplace risk and policy goals.
Using a credible resource for drug screening supplies helps support consistency and reliability across your program.
